WallStreetZenWallStreetZen

NASDAQ: AVTX
Avalo Therapeutics Inc Stock Ownership - Who owns Avalo Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Avalo Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mittie DoyleChief Medical Officer2026-06-101,084$13.10
$14.20kSell
Paul VarkiChief Legal Officer2026-06-101,081$13.10
$14.16kSell
Christopher Ryan SullivanChief Financial Officer2026-06-10138$13.10
$1.81kSell
Jennifer RileyChief Strategy Officer2026-06-10588$13.10
$7.70kSell
Mittie DoyleChief Medical Officer2026-05-28679$8.04
$5.46kBuy
Mittie DoyleChief Medical Officer2026-05-28679$16.00
$10.86kSell
Mittie DoyleChief Medical Officer2026-05-153,000$18.76
$56.28kSell
Mittie DoyleChief Medical Officer2026-05-153,000$12.65
$37.95kBuy
Christopher Ryan SullivanChief Financial Officer2026-05-0718,606$24.12
$448.81kSell
Christopher Ryan SullivanChief Financial Officer2026-05-0718,606$9.88
$183.83kBuy

1 of 6

AVTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVTX insiders and whales buy or sell their stock.

AVTX Shareholders

What type of owners hold Avalo Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC98.19%51,615,185$758.74MInsider
Robert Moscato Jr.17.03%8,952,643$131.60MInsider
Randal Jones12.10%6,359,900$93.49MInsider
Fmr LLC5.48%2,879,481$42.33MInstitution
Steven Boyd4.46%2,345,714$34.48MInsider
T Rowe Price Investment Management Inc4.11%2,162,684$31.79MInstitution
Caligan Partners LP3.11%1,635,023$24.03MInstitution
Patrick J. Crutcher3.11%1,634,771$24.03MInsider
Bvf Inc3.11%1,632,845$24.00MInstitution
Avoro Capital Advisors LLC2.68%1,410,000$20.73MInstitution

1 of 3

AVTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVTX27.61%72.39%Net SellingNet Selling
EVMN62.08%37.92%Net BuyingNet Selling
DSGN48.28%51.72%Net Selling
ZVRA69.89%21.79%Net SellingNet Buying
VOR74.65%23.50%Net SellingNet Selling
View Top Biotech Stocks

Avalo Therapeutics Stock Ownership FAQ

Who owns Avalo Therapeutics?

Avalo Therapeutics (NASDAQ: AVTX) is owned by 59.17% institutional shareholders, 155.15% Avalo Therapeutics insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Avalo Therapeutics shareholder, owning 51.62M shares representing 98.19% of the company. Armistice Capital LLC's Avalo Therapeutics shares are currently valued at $758.74M.

If you're new to stock investing, here's how to buy Avalo Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.